Human TRAILR4/TNFRSF10D Antibody AF633 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemHuman TRAILR4/TNFRSF10D Antibody
CompanyR&D Systems, a Bio-Techne Brand
Price $479.00Supplier Page View Company Product Page
Catalog NumberAF633
NCBI Gene AliasesTRAILR4, CD264, DCR2, TRUNDD, TRAIL-R4
ApplicationsFlow Cytometry,ELISA,Immunohistochemistry,Immunoprecipitation,Western Blot,Immunohistochemistry-Paraffin,Neutralization,Immunocytochemistry,CyTOF-ready,Cell Culture
Conjugate/TagUnconjugated
IsotypeIgG
FormatLyophilized from a 0.2 µm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS
Quantity100 ug (also 25 ug)
TargetTRAILR4/TNFRSF10D
ReactivityHuman
HostGoat
NCBI Full Gene NameTNF receptor superfamily member 10d
ClonalityPolyclonal
ImmunogenMouse myeloma cell line NS0-derived recombinant human TRAIL R4/TNFRSF10D, Ala56-His211, Accession # Q9UBN6
ConcentrationLYOPH
PurityAntigen Affinity-purified
Antibody TypePrimary Antibodies
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution

Specifications/Features

Available conjugates: Unconjugated

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Cytotoxic Efficacy and Resistance Mechanism of a TRAIL and VEGFA-Peptide Fusion Protein in Colorectal Cancer ModelsInternational journal of molecular sciencesMarch 19, 2021Kopczynski M, Statkiewicz M, Cybulska M, Kuklinska U, Unrug-Bielawska K, Sandowska-Markiewicz Z, Grochowska A, Gajewska M, Kulecka M, Ostrowski J, et al.R&D Systems, Minneapolis, MN, USA), TNFRSF10C (AF630, R&D Systems, Minneapolis, MN, USA), and TNFRSF10D (AF633, R&D Systems, Minneapolis, MN, USA). Cells were then incubated with donkey anti-goat secondary antibody

(2) Chemotherapeutic Agents Sensitize Resistant Cancer Cells to the DR5-Specific Variant DR5-B more Efficiently than to TRAIL by Modulating the Surface Expression of Death and Decoy ReceptorsCancersApril 30, 2020Аrtykov АА, Belov DA, Shipunova VO, Trushina DB, Deyev SM, Dolgikh DA, Kirpichnikov MP, Gasparian ME.bortezomib were from Santa Cruz (Dallas, TX, USA). Antibodies to decoy receptors DcR1 (AF630) and to DcR2 (AF633) were form R&D systems. 4.2. Expression and Purification of Recombinant Preparations TRAIL and DR5-B Recombinant

(3) Critical Role for Monocytes/Macrophages in Rapid Progression to AIDS in Pediatric Simian Immunodeficiency Virus-Infected Rhesus MacaquesJournal of virologySeptember 1, 2017Sugimoto C, Merino KM, Hasegawa A, Wang X, Alvarez XA, Wakao H, Mori K, Kim WK, Veazey RS, Didier ES, et al.antibody (BU1/75; Novus) was used for staining the tissue sections, followed by incubation with AF488-, AF568-, or AF633-conjugated secondary antibodies (1:1,000; Invitrogen). To maximize the SIV signal, a tyramide signal

(4) Dual role of DR5 in death and survival signaling leads to TRAIL resistance in cancer cellsCell death & diseaseAugust 31, 2017Shlyakhtina Y, Pavet V, Gronemeyer H.USA) (anti-EEA1 cat. AB2900). Antibodies for immunoprecipitation of DR5 (AF631), DR4 (AF347), DcR2 (AF633), TRAF2 (AF3277) and normal goat IgG (AB-108-C) were purchased from R&D Systems (Minneapolis, MN, USA).

(5) Resistance to TRAIL in non-transformed cells is due to multiple redundant pathwaysCell death & diseaseJuly 4, 2013van Dijk M, Halpin-McCormick A, Sessler T, Samali A, Szegezdi E.or goat polyclonal antibodies against TRAIL R3/TNFRSF10C (AF630) or TRAIL R4/TNFRSF10D antibodies (AF633; R&D Systems, Minneapolis, MN, USA) for 1 h on ice followed by either goat anti-mouse IgG-FITC (F2012;

(6) PTHrP Overexpression Increases Sensitivity of Breast Cancer Cells to Apo2L/TRAILPLoS ONEJune 18, 2013Vanessa Cheung, Steve Bouralexis, Matthew T. GillespieApo2L/TRAIL-R1/DR4 (AF347), Apo2L/TRAIL-R2/DR5 (AF631), Apo2L/TRAIL-R3/DcR1 (AF630), Apo2L/TRAIL-R4 (AF633), mouse IgG2B (MAB004), mouse IgG1 (MAB002), monoclonal antihuman Caspase-7 (MAB823), Caspase-8 (MAB704),

(7) Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cellsStem CellsNovember 1, 2008Secchiero P, Melloni E, Corallini F, Beltrami AP, Alviano F, Milani D, D'Aurizio F, di Iasio MG, Cesselli D, Bagnara GP, et al.

(8) Differential response of p53 and p21 on HDAC inhibitor-mediated apoptosis in HCT116 colon cancer cells in vitro and in vivoInternational journal of oncologyDecember 1, 2007Zopf S, Neureiter D, Bouralexis S, Abt T, Glaser KB, Okamoto K, Ganslmayer M, Hahn EG, Herold C, Ocker M.

(9) Acquired resistance to TRAIL-induced apoptosis in human ovarian cancer cells is conferred by increased turnover of mature caspase-3Molecular cancer therapeuticsMarch 1, 2006Lane D, Côté M, Grondin R, Couture MC, Piché A.

(10) Death receptors, Fas and TRAIL receptors, are involved in human osteoclast apoptosisBiochemical and biophysical research communicationsJuly 22, 2005Roux S, Lambert-Comeau P, Saint-Pierre C, Lépine M, Sawan B, Parent JL.

(11) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/AktThe Journal of biological chemistryApril 22, 2005Morel J, Audo R, Hahne M, Combe B.

(12) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cellsCirculation researchApril 18, 2003Zauli G, Pandolfi A, Gonelli A, Di Pietro R, Guarnieri S, Ciabattoni G, Rana R, Vitale M, Secchiero P.

Be the First to Write a Review!

TRAILR4/TNFRSF10D Antibody

TRAILR4/TNFRSF10D Antibody

TRAILR4/TNFRSF10D Antibody

TRAILR4/TNFRSF10D Antibody

TRAILR4/TNFRSF10D Antibody

Human TRAILR4/TNFRSF10D Antibody from R&D Systems, a Bio-Techne Brand

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (12)

Reviews

Human TRAILR4/TNFRSF10D Antibody from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map